LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Elanco Animal Health Inc

Suletud

SektorTervishoid

13.94 3.8

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

13.43

Max

14.04

Põhinäitajad

By Trading Economics

Sissetulek

75M

67M

Müük

173M

1.2B

P/E

Sektori keskmine

17.893

51.198

Aktsiakasum

0.37

Kasumimarginaal

5.616

Töötajad

9,000

EBITDA

86M

261M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

-1.71% downside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

7. aug 2025

Turustatistika

By TradingEconomics

Turukapital

1.9B

6.7B

Eelmine avamishind

10.14

Eelmine sulgemishind

13.94

Uudiste sentiment

By Acuity

34%

66%

95 / 380 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Elanco Animal Health Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. mai 2025, 11:29 UTC

Omandamised, ülevõtmised, äriostud

Elanco Sells Non-Core Asset to Blackstone for $295 Million

27. juuni 2024, 14:34 UTC

Suurimad hinnamuutused turgudel

Elanco Shares Retreat Over Zenrelia Warning Label Concerns

5. mai 2025, 11:14 UTC

Omandamised, ülevõtmised, äriostud

Elanco Sells Non-Core Asset to Blackstone for $295 Mln

5. mai 2025, 10:50 UTC

Omandamised, ülevõtmised, äriostud

Elanco Animal Health: Monetization of This Non-Core Asset Will Be Used to Accelerate Debt Reduction >ELAN

5. mai 2025, 10:49 UTC

Omandamised, ülevõtmised, äriostud

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone for $295M

9. juuli 2024, 12:30 UTC

Omandamised, ülevõtmised, äriostud

Merck Animal Health Completes Acquisition Of Elanco's Aqua Business >MRK

9. juuli 2024, 12:29 UTC

Omandamised, ülevõtmised, äriostud

Elanco Animal Health Sees Ending 2024 With Net Debt to Adjusted Ebitda in Mid-4x Range >ELAN

9. juuli 2024, 12:28 UTC

Omandamised, ülevõtmised, äriostud

Elanco Animal Health: $1.05B-$1.1B Net Proceeds Available for Debt Paydown in 3Q >ELAN

9. juuli 2024, 12:28 UTC

Omandamised, ülevõtmised, äriostud

Elanco Completes Sale of Aqua Business to Merck >ELAN MRK

Võrdlus sarnastega

Hinnamuutus

Elanco Animal Health Inc Prognoos

Hinnasiht

By TipRanks

-1.71% langus

12 kuu keskmine prognoos

Keskmine 13.2 USD  -1.71%

Kõrge 16 USD

Madal 10 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Elanco Animal Health Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

8 ratings

4

Osta

4

Hoia

0

Müü

Tehniline skoor

By Trading Central

9.77 / N/AToetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Weak Bullish Evidence

Sentiment

By Acuity

95 / 380 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.